Home/Filings/4/A/0001600620-24-000015
4/A//SEC Filing

Robertson Stephen P. 4/A

Accession 0001600620-24-000015

CIK 0001600620other

Filed

Feb 21, 7:00 PM ET

Accepted

Feb 22, 4:19 PM ET

Size

4.9 KB

Accession

0001600620-24-000015

Insider Transaction Report

Form 4/AAmended
Period: 2023-03-02
Robertson Stephen P.
EVP, General Counsel
Transactions
  • Sale

    Common Stock

    2023-03-02$8.78/sh19,644$172,474303,122 total
Footnotes (1)
  • [F1]Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of RSUs.

Issuer

Aurinia Pharmaceuticals Inc.

CIK 0001600620

Entity typeother

Related Parties

1
  • filerCIK 0001837798

Filing Metadata

Form type
4/A
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 4:19 PM ET
Size
4.9 KB